Infinity Pharmaceuticals Stock

Infinity Pharmaceuticals P/B

P/B (Price-to-Book Ratio) of Infinity Pharmaceuticals (INFIQ) as of Aug 4, 2026.

P/B

-0.00

YoY

-213.23%

Last updated:

P/B (Price-to-Book Ratio) of Infinity Pharmaceuticals is 2026 -0.00 . P/B (Price-to-Book Ratio) of Infinity Pharmaceuticals was 2025 0.00 . It decreases by -213.23% lower compared to the previous year.
Access this data via the Eulerpool API

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Infinity Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals